Your session is about to expire
← Back to Search
tVNS for Atrial Fibrillation (STOP_AF Trial)
STOP_AF Trial Summary
This trial is testing whether stimulating the vagus nerve non-invasively can help reduce atrial fibrillation (AF) after cardiac surgery. AF is a common complication after surgery, and can prolong hospital stays. This trial will test whether tVNS can help reduce the burden of AF and days of hospitalization.
STOP_AF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSTOP_AF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.STOP_AF Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are participants still being sought for this trial?
"As indicated on clinicaltrials.gov, this experiment is currently searching for volunteers; the original posting date was September 20th 2021 and the listing was last changed to December 21st of that same year."
Are geriatric patients eligible to join this research endeavor?
"For inclusion in this trial, participants must be aged 18 and over but must not have surpassed their 80th birthday."
Are there any eligibility criteria that would permit me to join this experiment?
"This clinical study is accepting 266 participants who have atrial fibrillation and are aged between 18 to 80 years."
What is the scope of participation for this research experiment?
"Indeed, according to the information on clinicaltrials.gov, this medical study is actively recruiting participants since its posting date of September 20th 2021 and most recent update of December 21st 2021. There are 266 patients needed from two different sites for enrollment in this trial."
Share this study with friends
Copy Link
Messenger